Encompass Health (EHC) Stock
Leading US provider of rehabilitation and home health. Here's the price, business snapshot, and what's worth knowing about Encompass Health in September 2026.
Encompass Health Corporation (EHC) is a leading US provider of post‑acute healthcare services, operating inpatient rehabilitation hospitals alongside home health and hospice services. Investors should know its revenue is driven largely by inpatient admissions, therapy intensity and occupancy rates, while the home health division offers a complementary, growing revenue stream. The company benefits from demographic trends (an ageing population), scale advantages and a track record of bolt‑on acquisitions, but is exposed to Medicare reimbursement rules, payor mix shifts, labour costs and local referral patterns. Financial performance can fluctuate with policy changes, seasonal demand and hospital referral relationships. Market capitalisation is around $12.6bn, reflecting investor expectations for steady post‑acute demand and margin improvement, though returns are not guaranteed. This information is general and educational only, not personal financial advice; investors should assess suitability, risks and consult a financial adviser before investing.
